Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen

Area of Science:

• Microbiology
• Immunology
• Rheumatology

Background:

• Acute rheumatic fever is a severe autoimmune condition following Streptococcus pyogenes infection.
• The mechanisms linking S. pyogenes to autoimmune sequelae are not fully understood.

Purpose of the Study:

• To investigate the interaction between rheumatogenic Streptococcus pyogenes strains and human collagen type IV.
• To explore the role of bacterial factors in collagen binding and potential autoimmune responses.

Main Methods:

• Isolation and characterization of S. pyogenes serotypes M3 and M18 from rheumatic fever outbreaks.
• In vitro and in vivo assays to assess collagen type IV binding.
• Analysis of M3 protein and hyaluronic acid capsule involvement.
• Immunization studies in mice and antibody titer analysis in patient sera.

Main Results:

• Rheumatogenic S. pyogenes serotypes M3 and M18 bind human collagen type IV.
• M3 protein mediates binding in M3 strains; hyaluronic acid capsule mediates binding in M18 strains.
• Collagen binding was confirmed as an in vitro and in vivo colonization mechanism.
• Mice immunized with M3 protein developed anti-collagen type IV antibodies.
• Acute rheumatic fever patients showed elevated anti-collagen type IV antibody titers.

Conclusions:

• Collagen type IV binding is a novel colonization mechanism for rheumatogenic S. pyogenes.
• The ability of S. pyogenes to bind collagen may trigger autoimmune responses against collagen in rheumatic fever patients.
• Anti-collagen type IV antibodies could be a basis for post-streptococcal rheumatic disease.